首页> 外国专利> Diagnosis-treatment Integrated nano-probe for 19F-MR/fluorescence multi-mode molecular imaging and drug-loading and preparation method and application of nano-probe

Diagnosis-treatment Integrated nano-probe for 19F-MR/fluorescence multi-mode molecular imaging and drug-loading and preparation method and application of nano-probe

机译:用于19F-MR /荧光多模分子成像和载药的诊疗一体化纳米探针及其制备方法和应用

摘要

The present invention provides a 19F-MR/fluorescence multi-mode molecular imaging and drug loading diagnosis-treatment integrated nanoprobe, and a preparation method and an application. The nano-probe is a nanoparticle formed by coating a mixture of a surfactant containing a molecular targeting treatment drug and a fluorescent dye with a Perfluorocarbon (PFC) carrier; and by uniformly dispersing a mixed solution into water and glycerol, processing ultrasonically, removing a component which is not effectively coated, and purifying, the drug-loading nanoparticle capable of being used for 19 F-MR imaging may be prepared. The nano-probe may implement in-vivo 19F-MR molecular imaging; a carried molecular targeting treatment drug can implement targeted binding and targeted treatment; and by virtue of a characteristic that PFC in a nucleus may carry and release oxygen massively, an anaerobious microenvironment in the tumor is improved, a chemosensitization effect is achieved, and thus the diagnosis-treatment integration of the tumor is implemented finally.
机译:本发明提供了一种 19 F-MR /荧光多模式分子成像与载药诊断-治疗一体化纳米探针,及其制备方法和应用。纳米探针是通过将含有分子靶向治疗药物的表面活性剂和荧光染料的混合物涂覆有全氟化碳(PFC)载体而形成的纳米颗粒。通过将混合溶液均匀地分散在水和甘油中,超声处理,去除未有效涂覆的组分,并纯化,可以制备能够用于19 F-MR成像的载药纳米颗粒。纳米探针可以实现体内19F-MR分子成像。携带的分子靶向治疗药物可以进行靶向结合和靶向治疗;并具有核中PFC可以大量携带和释放氧的特点,改善了肿瘤的厌氧微环境,达到了化学增敏作用,最终实现了肿瘤的诊治一体化。

著录项

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号